The University of Barcelona (UB) and Hospital Clínic de Barcelona collaborate with Boehringer Ingelheim Inc. to improve the efficiency of nintedanib, an antiangiogenic and antifibrotic drug, for the treatment of lung cancer. This public-private collaboration enabled researchers identify molecular mechanisms underlying the lack of efficiency of this drug in squamous cell carcinoma, a sub-type of non-small cell lung cancer, and the important role of smoking in this lack of effectivity.
New advances in the treatment of adva... - Lung Conditions C...
New advances in the treatment of advanced lung cancer.
Written by
2greys
To view profiles and participate in discussions please or .
Read more about...
Not what you're looking for?
You may also like...
Lung Cancer Treatment
Have been diagnosed with lung cancer again (but now on the right), 6 years later, but this time they
Lung Cancer Treatment
I have just been diagnosed with stage 3 lung cancer. To be precise I have T3 N2 MO, I have been...
has anyone here undergone Lung Surgery for cancer?
for lung cancer, in this instance, surgery.
my mum has been diagnosed with stage 3a lung cancer and
I'm really tired with all these ideas about lung cancer
me that the doctors might be wrong, I have lung cancer not pneumonia, when I try to remove...
Recurring Pneumonia from Breast Cancer radiation treatment
December 2022, I went through a lung lavage and tissue biopsy of the left lung, all on 12-23-2-22....